Impact of tobacco warning signs in stores
Implementation, reach, and impact of court-ordered tobacco corrective statement postings at the point-of-sale
This study is looking at how warning signs about the dangers of tobacco, placed in stores where you buy it, can help people understand the health risks and tricks used by tobacco companies, and it’s for anyone interested in reducing tobacco use and improving public health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11045203 on NIH RePORTER |
What this research studies
This research investigates the implementation and effects of court-ordered tobacco warning signs displayed at the point-of-sale in retail stores. It aims to assess how these signs inform consumers about the health risks associated with tobacco use and the deceptive practices of tobacco manufacturers. By collecting data from over 200,000 retailers, the study will evaluate the reach and effectiveness of these corrective statements in changing consumer behavior and attitudes towards tobacco products. The research will also explore the potential public health benefits of increased awareness about tobacco-related risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who are current tobacco users or are at risk of tobacco use.
Not a fit: Patients who do not use tobacco products or are not at risk of starting to use tobacco may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in tobacco use and related health issues among consumers.
How similar studies have performed: Previous research has shown that public health interventions, such as warning labels and educational campaigns, can effectively reduce tobacco use and improve health outcomes.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Wackowski, Olivia — Rutgers Biomedical and Health Sciences
- Study coordinator: Wackowski, Olivia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.